FOLFOXIRI Plus Cetuximab Versus FOLFOXIRI Plus Bevacizumab in Conversion Therapy of Right-sided Colon Cancer Liver Metastases

  • STATUS
    Recruiting
  • End date
    Dec 31, 2025
  • participants needed
    160
  • sponsor
    Fudan University
Updated on 15 April 2021

Summary

To compare the efficacy of FOLFOXIRI plus Cetuximab and FOLFOXIRI plus Bevacuzumab in the conversion therapy of right-sided colon cancer liver metastases

Details
Condition Liver Metastasis Colon Cancer
Treatment Cetuximab, bevacizumab, FOLFOXIRI
Clinical Study IdentifierNCT04832776
SponsorFudan University
Last Modified on15 April 2021

Eligibility

Yes No Not Sure

Inclusion Criteria

ECOG perfomance 0-1
pathologically confirmed colorectal carcinoma, with RAS wild type
inital unresectable liver metastases discussed by MDT
prior no systemical therapy or exceed 6 months after the adjuvant chemotherapy of primary tumor surgery
without extraheptic metastatic lesions, except for locally controlled lung metastases (RFA or SBRT)
adequate blood, liver and renal function
expected survival longer than 6 months

Exclusion Criteria

with bleeding risk
interestinal obstruction or disease
uncontrolled hypertension and severe heart disease
previous severe thrombotic events
central nervous system metastases
accompanied with other malignant tumor
Clear my responses

How to participate?

Step 1 Connect with a study center
What happens next?
  • You can expect the study team to contact you via email or phone in the next few days.
  • Sign up as volunteer to help accelerate the development of new treatments and to get notified about similar trials.

You are contacting

Investigator Avatar

Primary Contact

site

0/250

Additional screening procedures may be conducted by the study team before you can be confirmed eligible to participate.

Learn more

If you are confirmed eligible after full screening, you will be required to understand and sign the informed consent if you decide to enroll in the study. Once enrolled you may be asked to make scheduled visits over a period of time.

Learn more

Complete your scheduled study participation activities and then you are done. You may receive summary of study results if provided by the sponsor.

Learn more

Similar trials to consider

Loading...

Not finding what you're looking for?

Every year hundreds of thousands of volunteers step forward to participate in research. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.

Sign up as volunteer

user name

Added by • 

 • 

Private

Reply by • Private
Loading...

Lorem ipsum dolor sit amet consectetur, adipisicing elit. Ipsa vel nobis alias. Quae eveniet velit voluptate quo doloribus maxime et dicta in sequi, corporis quod. Ea, dolor eius? Dolore, vel!

  The passcode will expire in None.
Loading...

No annotations made yet

Add a private note
  • abc Select a piece of text from the left.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.
Add a private note